Beshir, K. B. , Sawa, P. , Drakeley, C. J. , Baidjoe, A. Y. , Mweresa, C. K. , Yussuf, R. U., Omar, S. A. , Hermsen, C. C., Shekalaghe, S. A. , Schallig, H. D. , Sauerwein, R. W. and Sutherland, C. J. (2012) Extended Malaria Parasite Clearance Time in African Children Following Artemisinincombination Therapy Enhances Transmission to Anopheles Mosquitoes. Malaria Journal, 11. ISSN 1475-2875
ihi14.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial.
Artemisinin resistance was recently shown to have spread or emerged on the Thailand/Myanmar border. Evidence is accumulating that the parasite clearance time after artemisinin-based combination therapy (ACT) is increasing in settings in Asia and Africa. It is currently unknown if an extended parasite clearance time after ACTs has consequences for the individual patient or confers a higher malaria transmission potential. 298 children in Mbita, Western Kenya, with uncomplicated falciparum malaria were randomized to artemether-lumefantrine (AL, n = 153) ordihydroartemisinin-piperaquine (DP, n = 145). Parasite carriage post-treatment was determined by microscopy and qPCR, gametocyte carriage by quantitative nucleic acid sequence based amplication. Infectiousness to mosquitoes was determined by mosquito membrane feeding assays. Both drugs were efficacious as judged by standard trial outcomes. Sub-patent residual parasitaemia on day 3 was detected by qPCR in 36.11% (95% CI 25.11 - 48.29) of children treated with AL, and in 30.16% (95% CI 19.23 - 43.02) of children treated with DP. After adjustment for age, treatment arm and enrolment parasite density, children with an extended parasite clearance time were significantly more likely to have microscopically detected recurrent parasitaemia during follow-up (Odds Ratio: 19.51, 95% CI 5.24 - 72.71, p < 0.001). Children with an extended parasite clearance time were also more likely to be infectious to mosquitoes (Odds Ratio 2.76; 95% CI 1.14 - 6.67, p = 0.02) and gave rise to a higher oocyst load in mosquitoes (Incidence Rate Ratio 2.80, 95% CI 1.49 - 5.24, p = 0.001). Our findings indicate that an extended parasite clearance time after ACTs has consequences for the individual patient and for the population at large due to higher transmission potential. The high prevalence of residual subpatent parasitaemia after treatment may be due to novel parasite genotypes with reduced drug sensitivity, inadequate population-level immunity, or the higher sensitivity of qPCR for detection of persisting parasites.
|Keywords:||Malaria Parasite;Artemisinincombination Therapy;Anopheles Mosquitoes|
|Subjects:||Malaria > Vector control
Malaria > Diagnosis & treatment
|Divisions:||Ifakara Health Institute > Biomedical|
|Depositing User:||Mr Joseph Madata|
|Date Deposited:||23 Jan 2013 09:20|
|Last Modified:||23 Jan 2013 09:20|
Actions (login required)
Downloads per month over past year